Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Price:
5.29 USD
-0.19%
Updated:
Jun 10, 2024
Aurinia Pharmaceuticals Inc
Total Current Assets
|
Aurinia Pharmaceuticals Inc
Total Current Assets Peer Comparison
Comparables:
ZYME
TH
RPTX
FUSN
EDT
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Current Assets
$398.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
25%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Current Assets
$412.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Total Current Assets
$57.9m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
19%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Current Assets
$243.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Current Assets
$243.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Total Current Assets
CA$3.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
See Also
What is Aurinia Pharmaceuticals Inc's Total Current Assets?
Total Current Assets
398.2m
USD
398.2m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Total Current Assets amounts to 398.2m USD.
What is Aurinia Pharmaceuticals Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
25%
25%
Over the last year, the Total Current Assets growth was -6%. The average annual Total Current Assets growth rates for Aurinia Pharmaceuticals Inc have been 2% over the past three years , 21% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
